Dose-dependent effects of eltrombopag iron chelation on platelet formation

Abstract: Iron deficiency is associated with thrombocytosis in patients, although thrombocytopenia can occur in cases of severe iron deficiency anemia. Eltrombopag (EP), a thrombopoietic agent approved for immune thrombocytopenia, also acts as an iron chelator. Our study demonstrates that megakaryoc...

Full description

Saved in:
Bibliographic Details
Main Authors: Elisabetta Bassi, Vittorio Abbonante, Alicia Aguilar, Hana Raslova, James B. Bussel, Christian Andrea Di Buduo, Alessandro Malara, Alessandra Balduini
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Blood Vessels, Thrombosis & Hemostasis
Online Access:http://www.sciencedirect.com/science/article/pii/S2950327225000178
Tags: Add Tag
No Tags, Be the first to tag this record!